rs693147

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_014956.5(CEP164):​c.3090-16A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.597 in 1,613,544 control chromosomes in the GnomAD database, including 292,162 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.60 ( 27686 hom., cov: 32)
Exomes 𝑓: 0.60 ( 264476 hom. )

Consequence

CEP164
NM_014956.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -1.03
Variant links:
Genes affected
CEP164 (HGNC:29182): (centrosomal protein 164) This gene encodes a centrosomal protein involved in microtubule organization, DNA damage response, and chromosome segregation. The encoded protein is required for assembly of primary cilia and localizes to mature centrioles. Defects in this gene are a cause of nephronophthisis-related ciliopathies. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2012]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 11-117396038-A-C is Benign according to our data. Variant chr11-117396038-A-C is described in ClinVar as [Benign]. Clinvar id is 260483.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.642 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CEP164NM_014956.5 linkc.3090-16A>C intron_variant Intron 24 of 32 ENST00000278935.8 NP_055771.4 Q9UPV0-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CEP164ENST00000278935.8 linkc.3090-16A>C intron_variant Intron 24 of 32 1 NM_014956.5 ENSP00000278935.3 Q9UPV0-1
CEP164ENST00000533223.1 linkn.3972-16A>C intron_variant Intron 10 of 15 1
CEP164ENST00000533675.5 linkn.3317-16A>C intron_variant Intron 18 of 26 2
CEP164ENST00000533706.5 linkn.2414-16A>C intron_variant Intron 17 of 26 5

Frequencies

GnomAD3 genomes
AF:
0.597
AC:
90669
AN:
151832
Hom.:
27648
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.648
Gnomad AMI
AF:
0.614
Gnomad AMR
AF:
0.431
Gnomad ASJ
AF:
0.571
Gnomad EAS
AF:
0.358
Gnomad SAS
AF:
0.488
Gnomad FIN
AF:
0.583
Gnomad MID
AF:
0.639
Gnomad NFE
AF:
0.632
Gnomad OTH
AF:
0.602
GnomAD3 exomes
AF:
0.539
AC:
135269
AN:
251188
Hom.:
38754
AF XY:
0.545
AC XY:
73991
AN XY:
135746
show subpopulations
Gnomad AFR exome
AF:
0.651
Gnomad AMR exome
AF:
0.292
Gnomad ASJ exome
AF:
0.554
Gnomad EAS exome
AF:
0.345
Gnomad SAS exome
AF:
0.493
Gnomad FIN exome
AF:
0.599
Gnomad NFE exome
AF:
0.628
Gnomad OTH exome
AF:
0.544
GnomAD4 exome
AF:
0.597
AC:
872013
AN:
1461594
Hom.:
264476
Cov.:
55
AF XY:
0.595
AC XY:
432436
AN XY:
727114
show subpopulations
Gnomad4 AFR exome
AF:
0.651
Gnomad4 AMR exome
AF:
0.312
Gnomad4 ASJ exome
AF:
0.556
Gnomad4 EAS exome
AF:
0.388
Gnomad4 SAS exome
AF:
0.493
Gnomad4 FIN exome
AF:
0.594
Gnomad4 NFE exome
AF:
0.624
Gnomad4 OTH exome
AF:
0.578
GnomAD4 genome
AF:
0.597
AC:
90754
AN:
151950
Hom.:
27686
Cov.:
32
AF XY:
0.590
AC XY:
43830
AN XY:
74278
show subpopulations
Gnomad4 AFR
AF:
0.648
Gnomad4 AMR
AF:
0.430
Gnomad4 ASJ
AF:
0.571
Gnomad4 EAS
AF:
0.358
Gnomad4 SAS
AF:
0.490
Gnomad4 FIN
AF:
0.583
Gnomad4 NFE
AF:
0.632
Gnomad4 OTH
AF:
0.604
Alfa
AF:
0.620
Hom.:
24373
Bravo
AF:
0.587
Asia WGS
AF:
0.458
AC:
1593
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

May 10, 2021
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Nephronophthisis 15 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.50
DANN
Benign
0.42

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs693147; hg19: chr11-117266754; COSMIC: COSV54042087; COSMIC: COSV54042087; API